IT1397912B1 - Nuovo polimorfo dell'estere 6-dietilamminometil-2-naftilico dell'acido 4-idrossicarbamoil-fenil-carbammico cloridrato. - Google Patents

Nuovo polimorfo dell'estere 6-dietilamminometil-2-naftilico dell'acido 4-idrossicarbamoil-fenil-carbammico cloridrato.

Info

Publication number
IT1397912B1
IT1397912B1 ITMI2010A000121A ITMI20100121A IT1397912B1 IT 1397912 B1 IT1397912 B1 IT 1397912B1 IT MI2010A000121 A ITMI2010A000121 A IT MI2010A000121A IT MI20100121 A ITMI20100121 A IT MI20100121A IT 1397912 B1 IT1397912 B1 IT 1397912B1
Authority
IT
Italy
Prior art keywords
naftylic
hydroxicarbamyl
diethylaminomethyl
phenyl
ester
Prior art date
Application number
ITMI2010A000121A
Other languages
English (en)
Inventor
Stefano Turchetta
Maurizio Zenoni
Original Assignee
Chemi Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to ITMI2010A000121A priority Critical patent/IT1397912B1/it
Application filed by Chemi Spa filed Critical Chemi Spa
Priority to PCT/IB2010/055560 priority patent/WO2011092556A1/en
Priority to US13/575,641 priority patent/US8518988B2/en
Priority to CN2010800535567A priority patent/CN102665712B/zh
Priority to PL10796492T priority patent/PL2528599T4/pl
Priority to AU2010344330A priority patent/AU2010344330B2/en
Priority to SI201030697T priority patent/SI2528599T1/sl
Priority to KR1020127013835A priority patent/KR101723532B1/ko
Priority to MX2012008777A priority patent/MX2012008777A/es
Priority to CA2780432A priority patent/CA2780432C/en
Priority to PT107964926T priority patent/PT2528599E/pt
Priority to RU2012134703/04A priority patent/RU2552354C2/ru
Priority to ES10796492.6T priority patent/ES2489467T3/es
Priority to EP10796492.6A priority patent/EP2528599B1/en
Priority to JP2012550524A priority patent/JP2013518091A/ja
Priority to DK10796492.6T priority patent/DK2528599T3/da
Priority to BR112012018626-4A priority patent/BR112012018626B1/pt
Publication of ITMI20100121A1 publication Critical patent/ITMI20100121A1/it
Publication of IT1397912B1 publication Critical patent/IT1397912B1/it
Application granted granted Critical
Priority to HK13102853.7A priority patent/HK1175699A1/xx
Priority to HRP20140610AT priority patent/HRP20140610T1/hr
Priority to CY20141100586T priority patent/CY1115409T1/el

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C271/00Derivatives of carbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
    • C07C271/06Esters of carbamic acids
    • C07C271/08Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms
    • C07C271/26Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atom of at least one of the carbamate groups bound to a carbon atom of a six-membered aromatic ring
    • C07C271/28Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atom of at least one of the carbamate groups bound to a carbon atom of a six-membered aromatic ring to a carbon atom of a non-condensed six-membered aromatic ring
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/21Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/27Esters, e.g. nitroglycerine, selenocyanates of carbamic or thiocarbamic acids, meprobamate, carbachol, neostigmine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • A61P37/06Immunosuppressants, e.g. drugs for graft rejection
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C271/00Derivatives of carbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
    • C07C271/06Esters of carbamic acids

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Immunology (AREA)
  • Emergency Medicine (AREA)
  • Rheumatology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Pain & Pain Management (AREA)
  • Transplantation (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
ITMI2010A000121A 2010-01-28 2010-01-28 Nuovo polimorfo dell'estere 6-dietilamminometil-2-naftilico dell'acido 4-idrossicarbamoil-fenil-carbammico cloridrato. IT1397912B1 (it)

Priority Applications (20)

Application Number Priority Date Filing Date Title
ITMI2010A000121A IT1397912B1 (it) 2010-01-28 2010-01-28 Nuovo polimorfo dell'estere 6-dietilamminometil-2-naftilico dell'acido 4-idrossicarbamoil-fenil-carbammico cloridrato.
ES10796492.6T ES2489467T3 (es) 2010-01-28 2010-12-03 Polimorfo novedoso del clorhidrato del éster (6-dimetilaminometil-2-naftalenílico) del ácido (4-hidroxicarbamoilfenil)-carbámico
US13/575,641 US8518988B2 (en) 2010-01-28 2010-12-03 Polymorph of the hydrochloride of the (4-hydroxycarbamoyl-phenyl)-carbamic acid (6-dimethylamino methyl-2-naphthalenyl) ester
PL10796492T PL2528599T4 (pl) 2010-01-28 2010-12-03 Nowy polimorf chlorowodorku estru (6-dwumetyloamino metylo-2-naftalenylowego) kwasu (4-hydroksykarbamoilo-fenylo)-karbamowego
AU2010344330A AU2010344330B2 (en) 2010-01-28 2010-12-03 Novel polymorph of the hydrochloride of the (4-hydroxycarbamoyl-phenyl)-carbamic acid (6-diethylamino methyl-2-naphtalenyl) ester
SI201030697T SI2528599T1 (sl) 2010-01-28 2010-12-03 Nov polimorf hidroklorida (6-dimetilamino-metil-2-naftalenil) estra (4-hidroksikarbamoil-fenil)-karbaminske kisline
KR1020127013835A KR101723532B1 (ko) 2010-01-28 2010-12-03 (4-히드록시카르바모일-페닐)-카르밤산 (6-디에틸아미노 메틸-2-나프탈에닐) 에스테르의 히드로클로라이드의 신규 다형체
MX2012008777A MX2012008777A (es) 2010-01-28 2010-12-03 Nuevo poliformo del clorhidrato del (6-dimetilaminometil-2-naftale nil) ester del acido (4-hidroxicarbamoil-fenil) carbamico.
EP10796492.6A EP2528599B1 (en) 2010-01-28 2010-12-03 Novel polymorph of the hydrochloride of the (4-hydroxycarbamoyl-phenyl)-carbamic acid (6-dimethylamino methyl-2-naphthalenyl) ester
PT107964926T PT2528599E (pt) 2010-01-28 2010-12-03 Novo polimorfo do cloridrato de éster 6-dimetilamino-metil-2- naftalenílico de ácido (4-hidroxicarbamoíl-fenil)-carbâmico
PCT/IB2010/055560 WO2011092556A1 (en) 2010-01-28 2010-12-03 Novel polymorph of the hydrochloride of the (4-hydroxycarbamoyl-phenyl)-carbamic acid (6-dimethylamino methyl-2-naphtalenyl) ester
CN2010800535567A CN102665712B (zh) 2010-01-28 2010-12-03 (4-羟基氨基甲酰基-苯基)-氨基甲酸(6-二甲基氨基甲基-2-萘基)酯的盐酸盐的新多晶型物
CA2780432A CA2780432C (en) 2010-01-28 2010-12-03 Novel polymorph of the hydrochloride of the (4-hydroxycarbamoyl-phenyl)-carbamic acid (6-diethylamino methyl-2-naphthalenyl) ester
JP2012550524A JP2013518091A (ja) 2010-01-28 2010-12-03 (4−ヒドロキシカルバモイル−フェニル)−カルバミン酸(6−ジメチルアミノメチル−2−ナフタレニル)エステルの塩酸塩の新規結晶多形
DK10796492.6T DK2528599T3 (da) 2010-01-28 2010-12-03 Ny polymorf af hydrochloridet af (4-hydroxycarbamoyl-phenyl)carbaminsyren (6-dimethylamino-methyl-2-naphthalenyl)ester
BR112012018626-4A BR112012018626B1 (pt) 2010-01-28 2010-12-03 Novo polimorfo de cloridrato do éster do (4-hdroxicarbamoil-fenil)-ácido carbâmico (6- dietilamino metil-2-naftalenil)
RU2012134703/04A RU2552354C2 (ru) 2010-01-28 2010-12-03 Полиморф гидрохлорида (6-диэтиламинометил-2-нафталенил)метилового эфира (4-гидроксикарбамоилфенил)-карбаминовой кислоты
HK13102853.7A HK1175699A1 (it) 2010-01-28 2013-03-07
HRP20140610AT HRP20140610T1 (hr) 2010-01-28 2014-06-26 Novi polimorf hidroklorida 6-dimetilaminometil-2-naftalenilnog estera (4-hidroksikarbamoilfenil)karbaminske kiseline
CY20141100586T CY1115409T1 (el) 2010-01-28 2014-08-04 Νεο πολυμορφο του υδροχλωρικου αλατος του (4-υδροξυκαρβαμοϋλ-φαινυλ)καρβαμικου (6-διμεθυλαμινο μεθυλ-2-ναφθαλενυλ)εστερα

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ITMI2010A000121A IT1397912B1 (it) 2010-01-28 2010-01-28 Nuovo polimorfo dell'estere 6-dietilamminometil-2-naftilico dell'acido 4-idrossicarbamoil-fenil-carbammico cloridrato.

Publications (2)

Publication Number Publication Date
ITMI20100121A1 ITMI20100121A1 (it) 2011-07-29
IT1397912B1 true IT1397912B1 (it) 2013-02-04

Family

ID=42288805

Family Applications (1)

Application Number Title Priority Date Filing Date
ITMI2010A000121A IT1397912B1 (it) 2010-01-28 2010-01-28 Nuovo polimorfo dell'estere 6-dietilamminometil-2-naftilico dell'acido 4-idrossicarbamoil-fenil-carbammico cloridrato.

Country Status (20)

Country Link
US (1) US8518988B2 (it)
EP (1) EP2528599B1 (it)
JP (1) JP2013518091A (it)
KR (1) KR101723532B1 (it)
CN (1) CN102665712B (it)
AU (1) AU2010344330B2 (it)
BR (1) BR112012018626B1 (it)
CA (1) CA2780432C (it)
CY (1) CY1115409T1 (it)
DK (1) DK2528599T3 (it)
ES (1) ES2489467T3 (it)
HK (1) HK1175699A1 (it)
HR (1) HRP20140610T1 (it)
IT (1) IT1397912B1 (it)
MX (1) MX2012008777A (it)
PL (1) PL2528599T4 (it)
PT (1) PT2528599E (it)
RU (1) RU2552354C2 (it)
SI (1) SI2528599T1 (it)
WO (1) WO2011092556A1 (it)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3858340A1 (en) 2012-02-03 2021-08-04 Italfarmaco SpA Diethyl-[6-(4-hydroxycarbamoyl-phenyl-carbamoyloxy-methyl)-naphthalen-2-yl-methyl]-ammonium chloride for use in the treatment of muscular dystrophy
ITUB20155193A1 (it) * 2015-11-03 2017-05-03 Italfarmaco Spa Sospensioni orali di Givinostat fisicamente e chimicamente stabili
IT201900003281A1 (it) * 2019-03-06 2020-09-06 Chemi Spa Processo per preparare {6-[(dietilammino)metil]naftalen-2-il}metil [4-(idrossicarbamoil)fenil]carbammato ad elevata purezza

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3574185B2 (ja) * 1994-09-02 2004-10-06 小松屋化学株式会社 無水クエン酸トリマグネシウムおよびその製法
IT1283637B1 (it) * 1996-05-14 1998-04-23 Italfarmaco Spa Composti ad attivita' antinfiammatoria ed immunosoppressiva
WO1997046526A1 (en) * 1996-06-07 1997-12-11 Eisai Co., Ltd. Stable polymorphs of donepezil (1-benzyl-4-[(5,6-dimethoxy-1-indanon)-2-yl]methylpiperidine) hydrochloride and process for production
ITMI20030063A1 (it) * 2003-01-17 2004-07-18 Italfarmaco Spa Cloridrato monoidrato dell'estere (6-dietilamminometil-naftalen-2-il)metilico dell'acido (4-idrossicarbammoil-fenil)carbammico.
PE20061319A1 (es) * 2005-04-22 2006-12-28 Wyeth Corp Cristales formados de clorhidrato de {[(2r)-7-(2,6-diclorofenil)-5-fluoro-2-3-dihidro-1-benzofurano-2-il]metil}amina
US7868169B2 (en) * 2005-08-16 2011-01-11 Teva Pharmaceutical Industries, Ltd. Crystalline rosuvastatin intermediate
KR100830003B1 (ko) * 2006-10-31 2008-05-15 씨제이제일제당 (주) 결정성 s-(-)-암로디핀 아디핀산 염 무수물 및 이의 제조방법
US8329695B2 (en) * 2007-08-03 2012-12-11 Boehringer Ingelheim International Gmbh Crystalline form of the free base N-[trans-4-[4-(cyclopropylmethyl)-1-piperazinyl]cyclohexyl]-4-[[(7r)-7-ethyl-5,6,7,8-tetrahydro-5-methyl-8-(1-methylethyl)-6-oxo-2-pteridinyl]amino]-3-methoxy-benzamide

Also Published As

Publication number Publication date
JP2013518091A (ja) 2013-05-20
ES2489467T3 (es) 2014-09-02
CA2780432C (en) 2017-02-21
MX2012008777A (es) 2012-09-07
RU2012134703A (ru) 2014-03-10
DK2528599T3 (da) 2014-06-30
SI2528599T1 (sl) 2014-09-30
PL2528599T4 (pl) 2014-11-28
ITMI20100121A1 (it) 2011-07-29
BR112012018626A8 (pt) 2017-12-19
RU2552354C2 (ru) 2015-06-10
CA2780432A1 (en) 2011-08-04
CN102665712A (zh) 2012-09-12
HK1175699A1 (it) 2013-07-12
BR112012018626B1 (pt) 2021-06-08
BR112012018626A2 (pt) 2016-05-03
PL2528599T3 (pl) 2014-10-31
PT2528599E (pt) 2014-07-18
EP2528599B1 (en) 2014-05-21
CN102665712B (zh) 2013-10-16
EP2528599A1 (en) 2012-12-05
HRP20140610T1 (hr) 2014-08-15
US8518988B2 (en) 2013-08-27
US20120302633A1 (en) 2012-11-29
WO2011092556A1 (en) 2011-08-04
AU2010344330A1 (en) 2012-05-24
KR20120123259A (ko) 2012-11-08
CY1115409T1 (el) 2017-01-04
KR101723532B1 (ko) 2017-04-06
AU2010344330B2 (en) 2014-11-13

Similar Documents

Publication Publication Date Title
SMT201500196B (it) Derivati dell'acido idrossammico
DK2623507T3 (da) Morpholinonukleinsyrederivat
PL2621923T3 (pl) Związki n-heteroarylu z mostkami cyklicznymi do leczenia chorób pasożytniczych
BR112013002925A2 (pt) processo para a síntese de ácido 2,5-furandicarboxílico
BR112012022750A2 (pt) "método de produção de radionuclídeos"
PL2618663T3 (pl) Zastosowanie kompozycji do zwiększania wydajności roślin użytkowych
FR2956074B1 (fr) Train d'entrainement
SMT201500107B (it) Nuovo polimorfo
EE201300004A (et) Kombineeritud ravimkoostis sdame-veresoonkonnaga seotud haiguste v?i seisundite raviks
FR2965705B1 (fr) Compositions d'edulcorants
DK3395796T3 (da) Krystallinsk trihydratform af (3s,3s') 4,4'-disulfandiylbis (3-aminobutan-1-sulfonsyre)
ITMI20110464A1 (it) Nuovo procedimento per la preparazione di erlotinib
BR112012025490A2 (pt) ''método para produção de 1,5 oebtanodiamina''
UY4030Q (es) Perfil en "t" de armazón destinada a un techo suspendido
BR112013012246A2 (pt) produção de ácido acético com uma velocidade de produção aumentada
IT1397912B1 (it) Nuovo polimorfo dell'estere 6-dietilamminometil-2-naftilico dell'acido 4-idrossicarbamoil-fenil-carbammico cloridrato.
IT1403587B1 (it) Composizione per il trattamento di disordini metabolici
FR2961401B1 (fr) Composition anti-inflammatoire
IT1394296B1 (it) Metodo di sintesi dell'acido glicocolico.
SMT201600071B (it) Derivato di acido pirrolidina-3-ilacetico
ITMI20110184A1 (it) Composti fotosensibilizzanti "metal free"
IT1399609B1 (it) Ifi16 extracellulare come agente terapeutico
IT1400485B1 (it) Nuovo processo per la preparazione dell'aminaftone
BR112012029363A2 (pt) 'método para produção de 1-alquil-3-difluormetil-5-hidroxipirazóis'
FR2963740B1 (fr) Systeme d'assistance respiratoire